Rappaport Reiches Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$380K Buy
460
+198
+76% +$165K 0.1% 76
2024
Q4
$202K Sell
262
-104
-28% -$86.1K 0.05% 106
2024
Q3
$325K Buy
366
+91
+33% +$81.8K 0.09% 79
2024
Q2
$249K Sell
275
-9
-3% -$7.2K 0.07% 80
2024
Q1
$221K Buy
+284
New +$202K 0.07% 91

Other funds holding LLY

Rappaport Reiches Capital Management's LLY Position: Q1 2025 in Review

Rappaport Reiches Capital Management increased its Eli Lilly (LLY) stake by 76% in Q1 2025, buying an estimated $165K and bringing the position to 460 shares worth $380K. The position accounts for 0.1% of the portfolio, ranked #76.

Rappaport Reiches Capital Management first reported a position in LLY in Q1 2024 and has held it in 5 quarters since. 3,919 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • Rappaport Reiches Capital Management held 460 shares of Eli Lilly worth $380K as of Q1 2025.
  • Rappaport Reiches Capital Management bought 198 Eli Lilly shares in Q1 2025, an estimated $165K.
  • Eli Lilly made up 0.1% of Rappaport Reiches Capital Management's portfolio in Q1 2025, its #76 holding.
  • Rappaport Reiches Capital Management first reported a position in Eli Lilly in Q1 2024 and has held it in 5 quarters since.
  • 3,919 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on Rappaport Reiches Capital Management's 13F filing for Q1 2025, filed 22 Apr 2025.